IOL Chemicals and Pharmaceuticals Limited Asset Resilience Ratio
IOL Chemicals and Pharmaceuticals Limited asset resilience ratio. IOL Chemicals and Pharmaceuticals Limited (IOLCP) has an Asset Resilience Ratio of 0.14% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See IOL Chemicals and Pharmaceuticals Limite (IOLCP) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of IOL Chemicals and Pharmaceuticals Limited (2005–2026)
Asset resilience ratio of IOL Chemicals and Pharmaceuticals Limited from 2005 to 2026. This chart shows how IOL Chemicals and Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Read IOL Chemicals and Pharmaceuticals Limite (IOLCP) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down IOL Chemicals and Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of IOL Chemicals and Pharmaceuticals Limite.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs35.10 Million | 0.14% |
| Total Liquid Assets | Rs35.10 Million | 0.14% |
Asset Resilience Insights
- Limited Liquidity: IOL Chemicals and Pharmaceuticals Limited maintains only 0.14% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
IOL Chemicals and Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio
Compare IOL Chemicals and Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Galderma Group N
SW:GALD |
Drug Manufacturers - Specialty & Generic | 3.56% |
|
Enzymatica publ AB
ST:ENZY |
Drug Manufacturers - Specialty & Generic | 22.17% |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
IOL Chemicals and Pharmaceuticals Limited Asset Resilience Ratio by Year (2005–2026)
IOL Chemicals and Pharmaceuticals Limited asset resilience ratio by year from 2005 to 2026. The table below shows the annual Asset Resilience Ratio data for IOL Chemicals and Pharmaceuticals Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 0.14% | Rs35.10 Million ≈ $379.59K |
Rs25.87 Billion ≈ $279.77 Million |
-5.37pp |
| 2025-03-31 | 5.50% | Rs1.31 Billion ≈ $14.18 Million |
Rs23.82 Billion ≈ $257.61 Million |
-0.50pp |
| 2024-03-31 | 6.01% | Rs1.35 Billion ≈ $14.58 Million |
Rs22.44 Billion ≈ $242.72 Million |
+4.93pp |
| 2023-03-31 | 1.08% | Rs217.50 Million ≈ $2.35 Million |
Rs20.22 Billion ≈ $218.69 Million |
-4.86pp |
| 2022-03-31 | 5.94% | Rs1.17 Billion ≈ $12.60 Million |
Rs19.62 Billion ≈ $212.22 Million |
-13.89pp |
| 2021-03-31 | 19.83% | Rs3.19 Billion ≈ $34.53 Million |
Rs16.10 Billion ≈ $174.13 Million |
+11.05pp |
| 2020-03-31 | 8.78% | Rs1.03 Billion ≈ $11.11 Million |
Rs11.70 Billion ≈ $126.51 Million |
+8.77pp |
| 2019-03-31 | 0.01% | Rs600.00K ≈ $6.49K |
Rs9.42 Billion ≈ $101.86 Million |
-2.03pp |
| 2018-03-31 | 2.04% | Rs173.80 Million ≈ $1.88 Million |
Rs8.52 Billion ≈ $92.15 Million |
+0.03pp |
| 2017-03-31 | 2.01% | Rs164.40 Million ≈ $1.78 Million |
Rs8.17 Billion ≈ $88.41 Million |
+2.01pp |
| 2016-03-31 | 0.01% | Rs457.23K ≈ $4.94K |
Rs7.76 Billion ≈ $83.91 Million |
+0.00pp |
| 2015-03-31 | 0.00% | Rs99.90K ≈ $1.08K |
Rs7.02 Billion ≈ $75.88 Million |
-1.20pp |
| 2012-03-31 | 1.20% | Rs82.56 Million ≈ $892.83K |
Rs6.87 Billion ≈ $74.29 Million |
-1.02pp |
| 2006-03-31 | 2.22% | Rs21.03 Million ≈ $227.45K |
Rs946.52 Million ≈ $10.24 Million |
+0.80pp |
| 2005-03-31 | 1.42% | Rs8.55 Million ≈ $92.50K |
Rs600.82 Million ≈ $6.50 Million |
-- |
About IOL Chemicals and Pharmaceuticals Limited
IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company operates through, Chemical and Pharmaceutical segments. The Chemical segment offers ethyl acetate, iso butyl benzene, acetyl chloride, mono chloro acetic acid, and acetic anhydride to food processing, flexible packaging, pharmaceuticals, textiles, ink, pa… Read more